Working Towards Eliminating Avoidable Harm

The activity of the SIG Working Towards Eliminating Avoidable Harm (financially supported by Baxter) centres around the supply, preparation and safe administration of all types of medicines in Europe. The group is evaluating current critical incidences and will be proposing approaches on how to minimise the occurrence of risks, critical incidents, and therefore also harm. The discussions of the SIG are going beyond the hospital pharmacy, meaning that the whole processes along the supply chain of medicinal products will be taken into account as well as the legal framework

.

Last update: 7 April 2022